Literature DB >> 4015954

Serum cholesterol and primary brain tumours: a case-control study.

Z H Abramson, J D Kark.   

Abstract

The objective of this study was to test the hypothesis that a positive relationship exists between high levels of serum cholesterol and primary brain tumours. A record-based case-control study was performed on male Jewish residents of Israel who were hospitalized at the Hadassah Ein Karem hospital in the years 1978-1982. A record check identified 37 cases of brain tumour who fulfilled the criteria for inclusion in the study and whose hospital files included the necessary data. For each case two controls were chosen randomly from all patients with inguinal hernia who met the respective matching criteria of age and year of hospitalization. The mean cholesterol value of the cases with brain tumours was 22 mg dl-1 higher than that of the controls. This difference was statistically significant (P = 0.007). Controlling for weight, region of birth, season of year, social class, medications and length of hospitalization before the measurement of cholesterol did not reduce the cholesterol difference, and in some instances increased it.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4015954      PMCID: PMC1977174          DOI: 10.1038/bjc.1985.154

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Increase in serum cholesterol during phenytoin treatment.

Authors:  R Pelkonen; R Fogelholm; E A Nikkilä
Journal:  Br Med J       Date:  1975-10-11

2.  Elevation of high-density lipoprotein in epileptic patients treated with phenytoin.

Authors:  E A Nikkilä; M Kaste; C Ehnholm; J Viikari
Journal:  Acta Med Scand       Date:  1978

3.  Statistical analysis of individually matched case-control studies in epidemiology: factor under study a discrete variable taking multiple values.

Authors:  M C Pike; J Casagrande; P G Smith
Journal:  Br J Prev Soc Med       Date:  1975-09

4.  Vitamin A nutrition and its relationship with plasma cholesterol level in the patients with cancer.

Authors:  T K Basu; R W Raven; J W Dickerson; D C Williams
Journal:  Int J Vitam Nutr Res       Date:  1974       Impact factor: 1.784

5.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

6.  Descriptive epidemiology of central nervous system neoplasms in Los Angeles County.

Authors:  S Preston-Martin; B E Henderson; J M Peters
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

Review 7.  Consideration of cholesterol and noncardiovascular mortality.

Authors:  R I Levy
Journal:  Am Heart J       Date:  1982-08       Impact factor: 4.749

8.  Plasma cholesterol. Can it be too low?

Authors:  M A Hlatky; S B Hulley
Journal:  Arch Intern Med       Date:  1981-08

9.  The epidemiology of inguinal hernia. A survey in western Jerusalem.

Authors:  J H Abramson; J Gofin; C Hopp; A Makler; L M Epstein
Journal:  J Epidemiol Community Health       Date:  1978-03       Impact factor: 3.710

10.  Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males inIsrael. II. Physiologic, biochemical and genetic characteristics.

Authors:  U Goldbourt; J H Medalie
Journal:  Am J Epidemiol       Date:  1977-01       Impact factor: 4.897

View more
  9 in total

1.  Serum cholesterol concentration and risk of primary brain tumours.

Authors:  P Knekt; A Reunanen; L Teppo
Journal:  BMJ       Date:  1991-01-12

2.  Occupational risk factors for brain tumors: results from a population-based case-control study in Germany.

Authors:  B Schlehofer; S Kunze; W Sachsenheimer; M Blettner; D Niehoff; J Wahrendorf
Journal:  Cancer Causes Control       Date:  1990-11       Impact factor: 2.506

3.  Plasma cholesterol concentration and primary brain tumours.

Authors:  G D Smith; M J Shipley
Journal:  BMJ       Date:  1989-07-01

4.  The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors.

Authors:  Jimmy T Efird; Gary D Friedman; Stephen Sidney; Arthur Klatsky; Laurel A Habel; Natalia V Udaltsova; Stephen Van den Eeden; Lorene M Nelson
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

5.  Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies.

Authors:  M R Law; S G Thompson
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

6.  Statin use, hyperlipidemia, and risk of glioma.

Authors:  David J Cote; Bernard A Rosner; Stephanie A Smith-Warner; Kathleen M Egan; Meir J Stampfer
Journal:  Eur J Epidemiol       Date:  2019-09-26       Impact factor: 8.082

7.  Circulating lipids and glioma risk: results from the UK Biobank, Nurses' Health Study, and Health Professionals Follow-Up Study.

Authors:  David J Cote; Stephanie A Smith-Warner; Jordan H Creed; Jeremy Furtado; Travis Gerke; Molin Wang; Youngchul Kim; Meir J Stampfer; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2021-01-23       Impact factor: 2.506

8.  Metabolic syndrome in relation to risk of meningioma.

Authors:  Corinna Seliger; Christoph R Meier; Claudia Becker; Susan S Jick; Martin Proescholdt; Ulrich Bogdahn; Peter Hau; Michael F Leitzmann
Journal:  Oncotarget       Date:  2017-01-10

9.  Tumours of the central nervous system and concentration of total serum cholesterol and beta-lipoprotein in men and women.

Authors:  O Gatchev; L Råstam; G Lindberg; B Gullberg; S Törnberg; G A Eklund
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.